These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 26867651

  • 1. Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report.
    Tian Y, Wang R, Liu L, Ma C, Lu Q, Yin F.
    BMC Musculoskelet Disord; 2016 Feb 11; 17():72. PubMed ID: 26867651
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Unilateral uveitis with vitreous haze following zoledronic Acid therapy for osteoporosis.
    Freitas-Neto CA, de Oliveira Fagundes WB, Ribeiro M, Pacheco KD, Freitas LG, Ávila MP.
    Semin Ophthalmol; 2015 May 11; 30(3):232-4. PubMed ID: 24168214
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The incidence of acute anterior uveitis after intravenous zoledronate.
    Patel DV, Horne A, House M, Reid IR, McGhee CN.
    Ophthalmology; 2013 Apr 11; 120(4):773-6. PubMed ID: 23290982
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
    Fitzpatrick SG, Stavropoulos MF, Bowers LM, Neuman AN, Hinkson DW, Green JG, Bhattacharyya I, Cohen DM.
    J Oral Maxillofac Surg; 2012 Feb 11; 70(2):325-30. PubMed ID: 21723015
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Osteoporosis and bisphosphonates].
    Zuber MA.
    Z Rheumatol; 2007 Dec 11; 66(8):713-5. PubMed ID: 17955251
    [No Abstract] [Full Text] [Related]

  • 12. Intravenous zoledronic acid and oral alendronate in patients with a low trauma fracture: experience from an osteoporosis clinic.
    Craig SJ, Youssef PP, Vaile JH, Sullivan L, Bleasel JF.
    Intern Med J; 2011 Feb 11; 41(2):186-90. PubMed ID: 20214696
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Yearly zoledronic acid in postmenopausal osteoporosis.
    Karam R, Camm J, McClung M.
    N Engl J Med; 2007 Aug 16; 357(7):712-3; author reply 714-5. PubMed ID: 17703529
    [No Abstract] [Full Text] [Related]

  • 15. Annual zoledronic acid for osteoporosis.
    BMJ Group.
    Drug Ther Bull; 2008 Dec 16; 46(12):93-6. PubMed ID: 19056701
    [Abstract] [Full Text] [Related]

  • 16. Intravenous zoledronic acid in postmenopausal women with low bone mineral density.
    Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, Widmer A, Devogelaer JP, Kaufman JM, Jaeger P, Body JJ, Brandi ML, Broell J, Di Micco R, Genazzani AR, Felsenberg D, Happ J, Hooper MJ, Ittner J, Leb G, Mallmin H, Murray T, Ortolani S, Rubinacci A, Saaf M, Samsioe G, Verbruggen L, Meunier PJ.
    N Engl J Med; 2002 Feb 28; 346(9):653-61. PubMed ID: 11870242
    [Abstract] [Full Text] [Related]

  • 17. Acute anterior uveitis following zoledronic acid infusion for osteoporosis.
    Belliveau MJ, Almeida DR, Urton TE.
    Can J Ophthalmol; 2012 Oct 28; 47(5):e22-3. PubMed ID: 23036555
    [No Abstract] [Full Text] [Related]

  • 18. Anterior uveitis complicating zoledronic acid infusion.
    Colucci A, Modorati G, Miserocchi E, Di Matteo F, Rama P.
    Ocul Immunol Inflamm; 2009 Oct 28; 17(4):267-8. PubMed ID: 19657981
    [Abstract] [Full Text] [Related]

  • 19. Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women.
    Boonen S, Sellmeyer DE, Lippuner K, Orlov-Morozov A, Abrams K, Mesenbrink P, Eriksen EF, Miller PD.
    Kidney Int; 2008 Sep 28; 74(5):641-8. PubMed ID: 18509324
    [Abstract] [Full Text] [Related]

  • 20. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density.
    Saag K, Lindsay R, Kriegman A, Beamer E, Zhou W.
    Bone; 2007 May 28; 40(5):1238-43. PubMed ID: 17347063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.